Personal information

No personal information available

Activities

Collapse all

Employment (7)

Columbia University Irving Medical Center Division of Neuroradiology: New York, NY, US

2022 to present | Associate Research Scientist (Molecular pharmacology and therapeutics)
Employment
Source: Self-asserted source
Chiho Kim

The University of Texas Southwestern Medical Center Medical School: Dallas, TX, US

2021 to 2022 | Instructor (Biochemistry)
Employment
Source: Self-asserted source
Chiho Kim

The University of Texas Southwestern Medical Center Medical School: Dallas, TX, US

2019 to 2021 | Research scientist (Biochemistry)
Employment
Source: Self-asserted source
Chiho Kim

University of Texas Southwestern Medical School: Dallas, TX, US

2017 to 2019 | Postdoctoral researcher (Biochemistry)
Employment
Source: Self-asserted source
Chiho Kim

University of Texas Southwestern Medical School: Dallas, TX, US

2015 to 2017 | Postdoctoral researcher (Neuroscience)
Employment
Source: Self-asserted source
Chiho Kim

Ewha Womans University: Seoul, KR

2014 to 2015 | Postdoctoral researcher (Brain and Cognitive Sciences)
Employment
Source: Self-asserted source
Chiho Kim

Yonsei University: Seodaemun-gu, Seoul, KR

2013 to 2014 | Postdoctoral researcher (Systems Biology)
Employment
Source: Self-asserted source
Chiho Kim

Education and qualifications (2)

Yonsei University: Seodaemun-gu, Seoul, KR

2006-03 to 2013-02 | PhD (Systems Biology)
Education
Source: Self-asserted source
Chiho Kim

Sogang University: Seoul, KR

2002-02 to 2006-02 | BS (Life Science)
Education
Source: Self-asserted source
Chiho Kim

Works (8)

Induced degradation of lineage-specific oncoproteins drives the therapeutic vulnerability of small cell lung cancer to PARP inhibitors

Science Advances
2024-01-19 | Journal article
DOI: 10.1126/sciadv.adh2579
Contributors: Chiho Kim; Xu-Dong Wang; Zhengshuai Liu; Jianwei Hao; Shuai Wang; Peng Li; Zhenzhen Zi; Qing Ding; Seoyeon Jang; Jiwoong Kim et al.
Source: check_circle
Crossref

Synthesis of nimbolide and its analogues and their application as poly(ADP-ribose) polymerase-1 trapping inducers

Nature Synthesis
2023-11-27 | Journal article
DOI: 10.1038/s44160-023-00437-w
Contributors: Heping Deng; Hejun Deng; Chiho Kim; Peng Li; Xudong Wang; Yonghao Yu; Tian Qin
Source: check_circle
Crossref

Nimbolide targets RNF114 to induce the trapping of PARP1 and synthetic lethality in BRCA -mutated cancer

Science Advances
2023-10-27 | Journal article
DOI: 10.1126/sciadv.adg7752
Contributors: Peng Li; Yuanli Zhen; Chiho Kim; Zhengshuai Liu; Jianwei Hao; Heping Deng; Hejun Deng; Min Zhou; Xu-Dong Wang; Tian Qin et al.
Source: check_circle
Crossref

Quantitative phosphoproteomic analyses identify STK11IP as a lysosome-specific substrate of mTORC1 that regulates lysosomal acidification

Nature Communications
2022-04-01 | Journal article
DOI: 10.1038/s41467-022-29461-8
Contributors: Zhenzhen Zi; Zhuzhen Zhang; Qiang Feng; Chiho Kim; Xu-Dong Wang; Philipp E. Scherer; Jinming Gao; Beth Levine; Yonghao Yu
Source: check_circle
Crossref

Quantitative Tyr Phosphoproteomic Analyses Identify Cholesterol as a Master Regulator of the Tumor Adaptive Resistance to MAPK Inhibition

2021-05-20 | Other
DOI: 10.1101/2021.05.20.444617
Contributors: Xu-Dong Wang; Chiho Kim; Yajie Zhang; Smita Rindhe; Melanie H. Cobb; Yonghao Yu
Source: check_circle
Crossref

Avoid the trap: Targeting PARP1 beyond human malignancy

Cell Chemical Biology
2021-04 | Journal article
DOI: 10.1016/j.chembiol.2021.02.004
Contributors: Chiho Kim; Chuo Chen; Yonghao Yu
Source: check_circle
Crossref

PARP1 inhibitors trigger innate immunity via PARP1 trapping-induced DNA damage response

eLife
2020-08-26 | Journal article
DOI: 10.7554/eLife.60637
Contributors: Chiho Kim; Xu-Dong Wang; Yonghao Yu
Source: check_circle
Crossref

PARP1 inhibitors trigger innate immunity via PARP1 trapping-induced DNA damage response

2020-07-12 | Preprint
DOI: 10.1101/2020.07.12.199349
Contributors: Chiho Kim; Xu-dong Wang; Yonghao Yu
Source: check_circle
Crossref
How many people are using ORCID?